InsidersTradesSigma
Discover the detailed record of transactions filed by Maryles Joel Michael, Director. Officer active across 1 companies, notably Chemomab Therapeutics Ltd.. In total, 2 filings have been logged. Total volume traded: €3k. The latest transaction was disclosed on 24 May 2022 — Acquisition. Regulator: SEC (Form 4). The full history is accessible without signup.
2 of 2 declarations
Joel Michael Maryles is a Director at Chemomab Therapeutics Ltd. In this role, he participates in overseeing management and making strategic decisions for the company. Joel brings his expertise in biotechnology and management, thus contributing to the strategic direction of Chemomab. His commitment to innovation and operational excellence is essential for the company's success.